Evaluation of the Quality of Life of Patients With Metastatic Non-small Cell Lung Cancer With Supplementary Therapy With IGEN-0206

NACompletedINTERVENTIONAL
Enrollment

266

Participants

Timeline

Start Date

June 11, 2019

Primary Completion Date

December 14, 2022

Study Completion Date

December 14, 2022

Conditions
Quality of Life of PatientsNon-small Cell Lung Cancer Metastatic
Interventions
DIETARY_SUPPLEMENT

IGEN0206

Group A

OTHER

Placebo

Group B

Trial Locations (25)

14004

Hospital Universitario Reina Sofía, Córdoba

15006

Complexo Hospitalario Universitario A Coruña, A Coruña

27003

Hospital Lucus Augusti, Lugo

28010

GenesisCare Madrid, Hospital La Milagrosa, Madrid

28023

Hospital Sanitas La Zarzuela, Madrid

28031

Hospital Universitario Infanta Leonor, Madrid

28040

Hospital Universitario Fundación Jiménez Díaz, Madrid

28046

Hospital Universitario La Paz, Madrid

28222

Hospital Universitario Puerta de Hierro, Majadahonda

28703

Hospital Universitario Infanta Sofía, San Sebastián de los Reyes

28822

Hospital del Henares, Coslada

28914

Hospital Universitario Severo Ochoa, Madrid

28935

Hospital Universitario de Móstoles, Móstoles

29010

Hospital Regional de Málaga, Málaga

32005

Complexo Hospitalario Universitario de Ourense, Ourense

39008

Hospital Universitario Marqués de Valdecilla, Santander

46015

Hospital Arnau de Vilanova, Valencia

46026

Hospital Universitari i Politècnic La Fe, Valencia

46520

Hospital de Sagunto, Sagunto

50009

Hospital Universitario Miguel Servet, Zaragoza

03804

Hospital Público Virgen de los Lirios, Alcoy

03203

Hospital General Universitario de Elche, Elche

03600

Hospital General Universitario de Elda, Elda

07198

Hospital Universitario Son Llatzer, Palma de Mallorca

03550

Hospital Universitario San Juan De Alicante, Alicante

All Listed Sponsors
lead

Igen BioLab SLU

INDUSTRY

NCT04009122 - Evaluation of the Quality of Life of Patients With Metastatic Non-small Cell Lung Cancer With Supplementary Therapy With IGEN-0206 | Biotech Hunter | Biotech Hunter